Lentiviral based HCV immunotherapy (GeneCure)

N/A

Report date: 2024/11/23 20:00:08

Base Information

Drug NameLentiviral based HCV immunotherapy (GeneCure)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis C, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenecure
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenecure Biotechnologies
Active IndicationsN/A
Inactive IndicationsHepatitis C, Chronic

Other Information

ATC CodeN/A
Related LinksN/A